We are live on
!
Find out more
CGIM
Capital Group Investment Management Portfolio holdings
AUM
$585M
1-Year Est. Return
31.36%
This Fund
S&P 500
This Quarter
Est. Return
-3.35%
1 Year Est. Return
+31.36%
3 Year Est. Return
+120.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$585M
AUM Growth
-$30.9M
(-5%)
Cap. Flow
+$10.6M
Cap. Flow
% of AUM
1.81%
Top 10 Holdings %
Top 10 Hldgs %
36.6%
Holding
150
New
11
Increased
61
Reduced
45
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$19.1M |
| 2 |
NVIDIA
NVDA
|
+$4.93M |
| 3 |
Amphenol
APH
|
+$4.24M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$4.13M |
| 5 |
Cadence Design Systems
CDNS
|
+$2.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$5.05M |
| 2 |
Flutter Entertainment
FLUT
|
+$3.69M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
+$2.85M |
| 4 |
Chubb
CB
|
+$2.81M |
| 5 |
Broadcom
AVGO
|
+$2.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.05% |
| 4 | Communication Services | 12.59% |
| 5 | Industrials | 10.77% |
Similar funds
HA
RIS
CM
TAM
GIM
KI
AIM
PFG
Capital Group Investment Management's Q1 2026 Portfolio in Review
As of Q1 2026, Capital Group Investment Management held 150 positions worth $585M, down 5% from $616M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Capital Group Investment Management's Q1 2026 filing shows 11 new, 61 increased, 45 reduced and 10 closed positions. Its largest new stake was AstraZeneca: 99,013 shares worth $19.3M. The largest sale was Synopsys, an estimated $5.05M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Capital Group Investment Management's largest Q1 2026 buy was AstraZeneca: 99,013 shares worth $19.3M.
- Capital Group Investment Management added most to NVIDIA in Q1 2026, an estimated $4.93M increase.
- Capital Group Investment Management's biggest Q1 2026 reduction was Alnylam Pharmaceuticals, cutting an estimated $2.85M.
- Capital Group Investment Management fully exited Synopsys in Q1 2026, selling an estimated $5.05M.
- Capital Group Investment Management's ten largest holdings make up 37% of its $585M portfolio in Q1 2026.
- Capital Group Investment Management opened 11 new positions and closed 10 in Q1 2026.
- Capital Group Investment Management's portfolio value fell 5% quarter-over-quarter to $585M.
Based on Capital Group Investment Management's 13F filing for Q1 2026, filed 13 May 2026.